Evidence map›Paper›PMID 19608542›Full record

ArticleInvestigative ophthalmology & visual science2009

Integrin alpha5beta1 mediates attachment, migration, and proliferation in human retinal pigment epithelium: relevance for proliferative retinal disease.

Rong Li, Arvydas Maminishkis, Grit Zahn, Doerte Vossmeyer, Sheldon S Miller

Abstract read
In one paragraph

Article in Investigative ophthalmology & visual science, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Mechanosensory entities and functionality of endothelial cells.Frontiers in cell and developmental biology · 2024
    Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Above the Matrix: Functional Roles for Apically Localized Integrins.Frontiers in cell and developmental biology · 2021
    Review
  10. Review
  11. ATN-161 as an Integrin α5β1 Antagonist Depresses Ocular Neovascularization by Promoting New Vascular Endothelial Cell Apoptosis.Medical science monitor : international medical journal of experimental and clinical research · 2018
    Article
  12. Article
  13. Retinal pigment epithelial cell proliferation.Experimental biology and medicine (Maywood, N.J.) · 2015
    Review
  14. Human T-Cell Development and Thymic Egress: An Infectious Disease Perspective.Forum on immunopathological diseases and therapeutics · 2015
    Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Rong LiNational Institutes of Health, National Eye Institute, Bethesda, Maryland 20892-2510, USA.
Arvydas Maminishkis
Grit Zahn
Doerte Vossmeyer
Sheldon S Miller
National Eye Institute · USNational Institutes of Health · US

Funding

Migration and proliferation of human retinal pigment epitheliumZ01EY000436 · NEI · NATIONAL EYE INSTITUTE · PI MILLER, SHELDON S · 2006 to 2008
$1.0M
Human retinal pigment epithelium proliferation, migration and fluid transportZIAEY000436 · NEI · NATIONAL EYE INSTITUTE · PI MILLER, SHELDON · 2009 to 2010
$402k
Role of integrin in RPE physiologyZIAEY000484 · NEI · NATIONAL EYE INSTITUTE · PI MILLER, SHELDON · 2009 to 2010
$201k
Intramural NIH HHS Z01 EY000436Intramural NIH HHS Z99 EY999999
6 · The paper itself

Abstract

purposeThe aim of this study was to determine the expression and localization of integrin alpha5beta1 in human retinal pigment epithelium (RPE) and its ability to modulate RPE cell attachment, proliferation, migration, and F-actin cytoskeleton distribution.

methodsExpression and localization of alpha5beta1 were analyzed on human RPE by immunoblot/immunofluorescence. Polarized secretion of fibronectin was measured. RPE attachments to different substrates were determined using cell attachment screening kits. BrdU incorporation and wound-healing assays were used to test hfRPE proliferation and migration. F-actin cytoskeleton was visualized with phalloidin.

resultsIntegrin alpha5beta1 was detected in native adult and fetal human RPE. The alpha5-subunit is predominantly localized at the apical membrane of hfRPE, whereas the beta1-subunit is uniformly detected at the apical/basolateral membranes. The authors also found that hfRPE cultures secrete significant amounts of fibronectin to the apical bath. JSM6427, a specific integrin alpha5beta1 antagonist, significantly inhibited hfRPE cell attachment to fibronectin, but not laminin, or collagen I or IV. JSM6427 also showed a strong inhibitory effect on bFGF, PDGF-BB, and serum-induced cell migration and proliferation. Furthermore, JSM6427 induced significant disruption of the F-actin cytoskeleton of dividing RPE cells but had no effect on quiescent cells.

conclusionsThe apical localization of alpha5beta1 and the secretion of fibronectin to the apical bath suggest the presence of an autocrine loop that can guide the migration of RPE. The strong inhibitory effects of JSM6427 on human RPE cell attachment, proliferation, and migration is probably mediated by F-actin cytoskeletal disruption in proliferating cells and suggests a potential clinical use of this compound in proliferative retinopathies.

Indexed as

Cell ProliferationActinsCell AdhesionCell MembraneCell MovementCells, CulturedFibronectinsFluorescent Antibody Technique, IndirectHumansImmunoblottingIntegrin alpha5beta1PropionatesPyridinesPyrrolidinesRetinal DiseasesRetinal Pigment EpitheliumActinsFibronectinsIntegrin alpha5beta1JSM6427PropionatesPyridinesPyrrolidines

Identifiers

PMID19608542
PMCPMC2788681
OpenAlexW2031540625

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.